Template:Smallpox Treatment: Difference between revisions
(→Active Disease: added clinical window for vaccine efficacy (before appearance of derm lesions). Helpful for cases with unknown last known exposure.) |
(→Active Disease: inserted reference) |
||
| Line 8: | Line 8: | ||
*Vaccinia Vaccine within the first 72hrs can decrease total disease severity and within 7 days may decrease symptoms | *Vaccinia Vaccine within the first 72hrs can decrease total disease severity and within 7 days may decrease symptoms | ||
*Supportive care and wound care for open lesions | *Supportive care and wound care for open lesions | ||
*Vaccination is not efficacious once the patient has developed rash | *Vaccination is not efficacious once the patient has developed rash<ref>https://www.cdc.gov/smallpox/prevention-treatment/index.html</ref> | ||
Revision as of 19:32, 11 September 2021
- IMMEDIATE NOTIFICATION OF PUBLIC HEALTH AUTHORITIES
- Vaccine administered up to 3 days post-exposure was effective in preventing infection as well as lessening the severity of the disease if infection occurred [1]
Postexposure Prophylaxis
- Vaccinia Vaccine (administer within 72hrs of exposure)
Active Disease
- Vaccinia Vaccine within the first 72hrs can decrease total disease severity and within 7 days may decrease symptoms
- Supportive care and wound care for open lesions
- Vaccination is not efficacious once the patient has developed rash[2]
- ↑ Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. 2008 May;26(2):517-47
- ↑ https://www.cdc.gov/smallpox/prevention-treatment/index.html